CATALYST PHARMACEUTICAL PARTNERS
CATALYST PHARMACEUTICAL PARTNERS Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20140336256 | METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS - The present invention is a method of treating Tourette's Disorder (TD) using GABA ergic drugs that elevate the amount of stored presynaptic GABA and do not significantly increase GABA tone (a continuous background level of GABA signaling) in the brain. The administration of vigabatrin and/or (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride salt is expressly contemplated. | 11-13-2014 |